The management of ductal carcinoma in situ of the breast: a screened population-based analysis
A recent SEER study identified significant variations in the care of women with DCIS, yet several potential confounding variables were not included. We report a patterns of care study of women with DCIS to better understand the gap between evidence-based knowledge and the management of DCIS.
We studied all cases of DCIS diagnosed through the Ontario Breast Screening Program from 1991 to 2000. Data was obtained by database linkage and chart abstraction. A logistic regression model using generalized estimating equations to adjust for clustering was used.
About 320,236 women were screened and 727 individuals were diagnosed with DCIS. The rate of mastectomy was 30% and was associated with multifocality (OR: 3.5 [1.7, 7.1], P = 0.0005), tumor size (OR: >2 cm vs. ≤1 cm: 2.7 [1.3, 5.9], P = 0.01), high nuclear grade (OR: 2.4 [1.1, 5.2], P = 0.03) and surgeon’s practice pattern. The rate of axillary dissection (AND) decreased from 36% in 1991–1993 to 20% in 1998–2000. AND was associated with mastectomy, year of surgery and hospital volume (OR: 2.7 [1.3, 5.6], P = 0.01). The use of radiation (XRT) following breast-conserving surgery increased from 39% in 1991␣to 51% in 2000. XRT was associated with age<70 years, high nuclear grade (OR: 2.7 [1.2, 6.3], P = 0.02) and tumor size > 1 cm (OR: 2.4 [1.3, 4.4], P = 0.006). Half of cases with margins <1 cm did not receive XRT.
Our study corroborates previous reports on the persistent rates of mastectomy and axillary nodal dissection and the limited use of XRT in the treatment of DCIS.
KeywordsDuctal carcinoma in situ Patterns of care Population-based
Unable to display preview. Download preview PDF.
- 3.Ernster VL, Barclay J (1997) Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma [review] [34 Refs]. J Natl Cancer Inst Monogr (22):151–156Google Scholar
- 4.Silverstein MJ (1997) Van nuys experience by treatment. In: Silverstein MJ (Eds), Ductal carcinoma in situ. Williams & Wilkins, Baltimore, pp 443–447Google Scholar
- 5.Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol 16(2):441–452PubMedGoogle Scholar
- 6.Fourquet A, Zafrani B, Campana F, Clough KB (1997) Institute curie experience. In: Silverstein MJ (Eds.), Ductal carcinoma in situ. Williams & Wilkins, Baltimore, pp 385–390Google Scholar
- 7.Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, Kuske R, Taylor M, Barrett W, Fowble B, Haffty B, Schultz DJ, Yeh IT, McCormick B, McNeese M (1996) Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14(3):754–763PubMedGoogle Scholar
- 10.Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F, Bartelink H (1998) Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European organization for research and treatment of cancer (EORTC), Breast cancer co-operative group (BCCG). Eur J Cancer 34(3):307–314PubMedCrossRefGoogle Scholar
- 12.Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, van Dongen JA (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC breast cancer cooperative group and EORTC radiotherapy group. Lancet 355(9203):528–533PubMedCrossRefGoogle Scholar
- 13.Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M (2003) UK coordinating committee on cancer research, ductal carcinoma in situ working party, and DCIS trialists in the UK, Australia and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New␣Zealand: randomised controlled trial. Lancet 362(9378):95–102PubMedCrossRefGoogle Scholar
- 14.Hansen N, Giuliano AE (1997) Axillary dissection for ductal carcinoma in situ. In: Silverstein MJ (Eds) Ductal carcinoma in situ. Williams and Wilkins, Baltimore, pp 577–584Google Scholar
- 15.Steering Committee on Clinical Practice Guidelines for the Care, Treatment of Breast Cancer (1998) The management of ductal carcinoma in situ (DCIS). Can Med Assoc J 158(3 Suppl):S27–S34Google Scholar
- 30.Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DAA (2003) Comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer [Report]. Breast Cancer Res Treat 77(3):285–293PubMedCrossRefGoogle Scholar
- 31.SchwartzGF (1994) The role of excision and surveillance alone in subclinical DCIS of the breast. Oncology (Huntingt) 8(2):21–26 discussionGoogle Scholar
- 34.Solin LJ, Fourquet A, McCormick B, Haffty B, Recht A, Schultz DJ, Barrett W, Fowble BL, Kuske R, Taylor M (1994) Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 30(1):3–9PubMedGoogle Scholar